1,279.2 1,380.7 FY19 FY20 FY21 FY22 FY23 1,594.8 715.3 920.7 50,192.2 FY19 FY20 FY21 FY22 FY23 48,467.5 45,510.3 44,534.3 45,053.3 5,573.0 5,033.3 4,912.8* Singapore 3,886.5 4,289.8 FY19 FY20 FY21 FY22 FY23 Singapore FY19 FY20 FY21 FY22 FY23 1,626.7 1,693.0 1,359.5 1,475.1 1,483.9* 3,683.6 2,727.2 3,073.7* Malaysia 2,187.1 2,331.1 FY19 FY20 FY21 FY22 FY23 Malaysia FY19 FY20 FY21 FY22 FY23 937.3 760.1 555.9 675.2 846.8* 14.53 FY19 FY20 FY21 FY22 FY23 15.09 17.15 7.13 9.49 India FY19 FY20 FY21 FY22 FY23 600.4 664.5 200.5 360.0 492.3* 3,554.5 3,728.8 3,175.1* India 2,655.8 3,320.9 FY19 FY20 FY21 FY22 FY23 5,945.1 4,347.2 Türkiye and Europe 3,462.2 3,764.7 4,455.3* FY19 FY20 FY21 FY22 FY23 Türkiye and Europe FY19 FY20 FY21 FY22 FY23 1,198.9 796.1 853.5 1,058.2* 1,249.2 Financial Highlights Group Overview Revenue by Strategic Business Units (RM million) EBITDA by Strategic Business Units (RM million) Profit After Tax and Minority Interest (PATMI) excluding exceptional items (RM million) Basic Earnings per Share excluding exceptional items (sen) Total Assets (RM million) * Restated FY2022 due to Labs being a separate business segment. In the charts above, prior to FY2022, Labs was classified as part of the Singapore, Malaysia, India, and Türkiye and Europe Hospital and Healthcare business segment. The above charts are not drawn to scale. See pages 42 to 43 on Financial Review for more information. IHH Healthcare Berhad 12
RkJQdWJsaXNoZXIy NDgzMzc=